Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuropharmacology

• Publication date

  2015-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2015.01.019PMID 25656478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

  2015cited by this paper
• Function of Inhibitory Micronetworks Is Spared by Na+ Channel-Acting Anticonvulsant Drugs

  2014cited by this paper
• Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.

  2013cited by this paper
• Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.

  2013cited by this paper
• Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers

  2013cited by this paper
• Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers

  2013cited by this paper
• Management of juvenile myoclonic epilepsy.

  2013cited by this paper
• Pharmacokinetics and drug interactions of eslicarbazepine acetate

  2012cited by this paper
• Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.

  2011cited by this paper
• Eslicarbazepine Acetate

  2009cited by this paper
• Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures

  2009cited by this paper
• Eslicarbazepine acetate: a new option for the treatment of focal epilepsy

  2009cited by this paper
• Seizure Aggravation—Evidence that Oxcarbazepine Requires Monitoring

  2008cited by this paper
• Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

  2008cited by this paper
• Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus

  2008cited by this paper
• Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment

  2008cited by this paper
• The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons.

  2008cited by this paper
• Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.

  2008cited by this paper
• Aggravation of Seizures and/or EEG Features in Children Treated with Oxcarbazepine Monotherapy

  2007cited by this paper
• Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2‐093), a new voltage‐gated sodium channel blocker

  2007cited by this paper
• Aggravation of epilepsy by anti‐epileptic drugs

  2006cited by this paper
• The Mechanism of Carbamazepine Aggravation of Absence Seizures

  2006cited by this paper
• Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.

  2006cited by this paper
• RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE

  2005influential reference
• 2-Chloro-N6-cyclopentyladenosine enhances the anticonvulsant action of carbamazepine in the mouse maximal electroshock-induced seizure model.

  2005cited by this paper
• Overview of the Clinical Pharmacokinetics of Oxcarbazepine

  2004cited by this paper
• A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.

  2004cited by this paper
• Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype‐dependent manner

  2004cited by this paper
• Worsening of Seizures by Oxcarbazepine in Juvenile Idiopathic Generalized Epilepsies

  2004cited by this paper
• Seizure Suppression by Adenosine A1 Receptor Activation in a Mouse Model of Pharmacoresistant Epilepsy

  2003cited by this paper
• Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats

  2003cited by this paper
• Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus.

  2003cited by this paper
• New Antiepileptic Drugs

  2002cited by this paper
• Adenosine A1 receptor agonism in the immature rat brain and heart

  2001cited by this paper
• Adenosine A(1) receptor agonism in the immature rat brain and heart.

  2001cited by this paper
• Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?

  2000cited by this paper
• Oxcarbazepine: a review.

  2000cited by this paper
• Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures.

  2000cited by this paper
• Effect of adenosinergic modulation on the anticonvulsant effect of phenobarbitone and carbamazepine.

  1999cited by this paper
• Modulation of Sodium Currents in Rat CA1 Neurons by Carbamazepine and Valproate After Kindling Epileptogenesis

  1999cited by this paper
• Aggravation of Generalized Epilepsies

  1998cited by this paper
• Antiepileptic Drugs as a Cause of Worsening Seizures

  1998cited by this paper
• A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels.

  1998cited by this paper
• Massive carbamazepine overdose: clinical and neurophysiological findings

  1998cited by this paper
• Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy.

  1997cited by this paper
• Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphosphate formation in hippocampal astrocyte cultures.

  1996cited by this paper
• Loss of A1 adenosine receptors in human temporal lobe epilepsy.

  1996cited by this paper
• Identification of Domains of the Human A1 Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A1/A2a Adenosine Receptors (*)

  1995cited by this paper
• Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus.

  1994cited by this paper
• Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.

  1994cited by this paper
• Effects of carbamazepine on action potentials and calcium currents in rat spinal ganglion cells in vitro.

  1993cited by this paper
• Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole- cell recording

  1992cited by this paper
• Exacerbation of Partial Seizures and Onset of Nonepileptic Myoclonus with Carbamazepine

  1991cited by this paper
• Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses.

  1991cited by this paper
• Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.

  1991cited by this paper
• Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus.

  1991cited by this paper
• Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine.

  1990cited by this paper
• Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.

  1989cited by this paper
• Transient and selective blockade of adenosine A1-receptors by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in hippocampal CA3 neurons of guinea pigs.

  1989cited by this paper
• Effect of carbamazepine on stimulus-evoked Ca2+ fluxes in rat hippocampal slices and its interaction with A1-adenosine receptors.

  1988cited by this paper
• Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy.

  1987cited by this paper
• Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture.

  1986cited by this paper
• Chronic Carbamazepine Treatment Increases Brain Adenosine Receptors

  1985cited by this paper
• Electrophysiological and neurochemical investigations on the action of carbamazepine on the rat hippocampus.

  1985cited by this paper
• Adenosine actions on CA1 pyramidal neurones in rat hippocampal slices.

  1985cited by this paper
• Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats.

  1984cited by this paper
• Specific and potent interactions of carbamazepine with brain adenosine receptors.

  1983influential reference
• Interactions of the Anticonvulsant Carbamazepine with Adenosine Receptors. 1. Neurochemical Studies

  1983cited by this paper
• Analysis of carbamazepine actions in hippocampal slices of the rat

  1983cited by this paper
• A purinergic component in the anticonvulsant action of carbamazepine?

  1982cited by this paper
• Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine

  1982cited by this paper
• Cyclic AMP Accumulation in Cerebral Cortical Slices: Effect of Carbamazepine, Phenobarbital, and Phenytoin

  1977cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

  1968cited by this paper
• Use of carbamazepine in epilepsy. Results in 87 patients.

  1967cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• COMPARATIVE ASSAY OF ANTIEPILEPTIC DRUGS BY "PSYCHOMOTOR" SEIZURE TEST AND MINIMAL ELECTROSHOCK THRESHOLD TEST

  1953cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper

• Anti-seizure medication eslicarbazepine affects the synaptic transmission and plasticity in the rat hippocampal synapses.

  2025cites this paper
• Eslicarbazepine as a Treatment for Vestibular Paroxysmia: Preliminary Results.

  2025cites this paper
• SCN8A Epileptic Encephalopathy Mutation Displays a Loss-of-Function Phenotype and Distinct Insensitivity to Valproate.

  2025cites this paper
• An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database.

  2024cites this paper
• Mechanism of Anti-seizure Medications and Emerging Trends in Epilepsy Treatment

  2023cites this paper
• Caffeine and Its Interactions with Antiseizure Medications—Is There a Correlation between Preclinical and Clinical Data?

  2023cites this paper
• In vitro effects of eslicarbazepine (S‐licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders

  2022cites this paper
• Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report

  2021cites this paper
• Drug treatment of epilepsy: From serendipitous discovery to evolutionary mechanisms.

  2021cites this paper
• In vitro and in vivo anti‐epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2‐related self‐limited epilepsy

  2021cites this paper
• Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study

  2020cites this paper
• SCN9A Epileptic Encephalopathy Mutations Display a Gain-of-function Phenotype and Distinct Sensitivity to Oxcarbazepine

  2019cites this paper
• Understanding Genotypes and Phenotypes of Voltage-Gated Sodium Channel Mutations in Epilepsy.

  2019cites this paper
• Inhibition of RPTPβ/ζ blocks ethanol-induced conditioned place preference in pleiotrophin knockout mice.

  2019cites this paper
• Carbamazepine Attenuates Astroglial L-Glutamate Release Induced by Pro-Inflammatory Cytokines via Chronically Activation of Adenosine A2A Receptor

  2019influential citation
• Prenatal Exposure to Oxcarbazepine Increases Hippocampal Apoptosis in Rat Offspring.

  2019cites this paper
• Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies

  2018cites this paper
• Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy

  2018cites this paper
• Pooled efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: Data from four double‐blind placebo‐controlled pivotal phase III clinical studies

  2017cites this paper
• Adenosine receptor agonists differentially affect the anticonvulsant action of carbamazepine and valproate against maximal electroshock test-induced seizures in mice

  2017influential citation
• Probing the synaptic target of a new putative antiepileptic drug: modulation of the excitatory transmission in the hippocampus

  2016cites this paper
• The Influence of Solid Microneedles on the Transdermal Delivery of Selected Antiepileptic Drugs

  2016cites this paper
• SYNTHESIS, MOLECULAR DOCKING AND ANTI-HUMAN BREAST CANCER ACTIVITIES OF NOVEL THIAZOLYLACETONITRILES AND THIAZOLYLACRYLONITRILES AND THEIR DERIVATIVES CONTAINING BENZENESULFONYLPYRROLIDINE MOIETY

  2016cites this paper
• Radiolysis of carbamazepine aqueous solution using electron beam irradiation combining with hydrogen peroxide: Efficiency and mechanism

  2016cites this paper
• 1-(4-(Pyrrolidin-1-ylsulfonyl)phenyl) ethanone in Heterocyclic Synthesis: Synthesis, Molecular Docking and Anti-Human Liver Cancer Evaluation of Novel Sulfonamides Incorporating Thiazole, Imidazo(1,2-a)pyridine, Imidazo(2,1-c)

  2015cites this paper